Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment
Clinical trial NCT06405217 · RECRUITING
Trial details
- NCT number
- NCT06405217
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-20
- Primary completion
- 2026-03-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.